Available for Humalog®, Humulin® R U-100, Humulin® 70/30, and Humulin® N

Door to door, Lilly supports diabetes management in your facility

Diabetes care isn’t limited to one part of your facility. And it means providing more than insulin. So Lilly has solutions for skilled nursing facilities to help from the moment a resident comes through your doors until they leave your care.

Our goal with each facility goes beyond choosing insulins. We want to support your never-ending goal of providing the best possible diabetes care.

Select Safety Information

Changes in insulin regimen may affect glycemic control and predispose patients to hypoglycemia and hyperglycemia. Changes should be made cautiously and the frequency of blood glucose monitoring should be increased.

For more information on how they can help your institution, talk to your Lilly Diabetes Sales Representative or call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).

Safely injecting insulin at mealtime

Administering mealtime insulin safely to each resident during their stay is a goal we share. That’s why Lilly Diabetes will provide your staff with in-house injection training presented by experienced nurses who are trained diabetes educators. We also offer materials and videos you can use to help educate staff on how to inject safely with a vial and syringe. Because we understand how important safely administering mealtime insulin is to residents’ well-being.

Encouraging safe injection practices

Safely injecting with vial and syringe

This video shows how to safely inject Humalog using a vial and syringe in an institutional setting.

When used properly, the vial and syringe are a safe method of insulin delivery and may be the preferred method in the institutional setting.

Select Safety Information

Adverse reactions associated with Humalog include hypoglycemia, hypokalemia, allergic reactions, injection-site reactions, lipodystrophy, pruritus, rash, weight gain, and peripheral edema.

When education is a goal, Lilly is there

Lilly offers support resources that provide guidance to staff and their residents regarding initiation and the maintenance of mealtime insulin therapy. These include:

  • Training staff on topics ranging from general diabetes information to discharge planning
  • Teaching residents and their caregivers how to manage diabetes after they leave your care
  • Making the transition to mealtime insulin achievable for residents

Continuing diabetes care after patients leave

Because patients’ diabetes care doesn’t end when they go home, we know that the healthcare professionals at your facility work hard to ensure patients are comfortable and confident with their mealtime insulin routine. We want to support that effort.

Training patients to use Humalog KwikPen when they leave

The Humalog KwikPen training is focused on preparing patients and caregivers to use the device after they leave your care.

Watch a video showing how to safely inject insulin using a Humalog KwikPen at home